Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
about
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.
P2860
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enhancing the Oncolytic Activi ...... titis Virus Are Most Effective
@en
type
label
Enhancing the Oncolytic Activi ...... titis Virus Are Most Effective
@en
prefLabel
Enhancing the Oncolytic Activi ...... titis Virus Are Most Effective
@en
P2093
P2860
P356
P1476
Enhancing the Oncolytic Activi ...... titis Virus Are Most Effective
@en
P2093
Alexander Muik
Camilo Ayala-Breton
Christian J Buchholz
Dina Kleinlützum
Julia D S Hanauer
Kay-Martin Hanschmann
Michael D Mühlebach
Sarah-Katharina Kays
Tobias Abel
P2860
P356
10.3389/FONC.2017.00127
P577
2017-06-26T00:00:00Z